A comparative analysis of C57BL/6J and 6N substrains; chemokine/cytokine expression and susceptibility to laser-induced choroidal neovascularization

Experimental Eye Research

Volumn 129, Issue , 2014, Pages 18-23

  Schnabolk, Gloriane ^a   Stauffer, Kimberly ^b   O'Quinn, Elizabeth ^b   Coughlin, Beth ^b   Kunchithapautham, Kannan ^b   Rohrer, Bärbel ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Para inflammation; Pre conditioning; Rd8 mutation

Indexed keywords

ANGIOGENIC FACTOR; CHEMOKINE; CYTOKINE; RNA;

AGE RELATED MACULAR DEGENERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; C57BL/6N MOUSE; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SUBRETINAL NEOVASCULARIZATION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHOROIDAL NEOVASCULARIZATION; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LASER; MALE; METABOLISM;

ANIMALS; CHEMOKINES; CHOROIDAL NEOVASCULARIZATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; LASERS; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; RNA;

EID: 84908456791     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.10.005     Document Type: Article

References (29)

1. Campbell M., Doyle S.L. An eye on the future of inflammasomes and drug development in AMD. J.Mol. Med. 2013, 91:1059-1070.
2. Chakravarthy U., Wong T.Y., Fletcher A., Piault E., Evans C., Zlateva G., Buggage R., Pleil A., Mitchell P. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010, 10:31.
3. de Oliveira Dias J.R., Rodrigues E.B., Maia M., Magalhaes O., Penha F.M., Farah M.E. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy. Br. J. Ophthalmol. 2011, 95:1631-1637.
4. Dong A., Xie B., Shen J., Yoshida T., Yokoi K., Hackett S.F., Campochiaro P.A. Oxidative stress promotes ocular neovascularization. J.Cell. Physiol. 2009, 219(3):544-552.
5. Giani A., Thanos A., Roh M.I., Connolly E., Trichonas G., Kim I., Gragoudas E., Vavvas D., Miller J.W. Invivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 2011, 52:3880-3887.
6. Heiker J.T., Kunath A., Kosacka J., Flehmig G., Knigge A., Kern M., Stumvoll M., Kovacs P., Bluher M., Kloting N. Identification of genetic loci associated with different responses to high fat diet induced obesity (DIO) in C57BL/6N and C57BL/6J substrains. Physiol. Genomics 2014, 46(11):377-384.
7. Kumar V., Kim K., Joseph C., Kourrich S., Yoo S.H., Huang H.C., Vitaterna M.H., de Villena F.P., Churchill G., Bonci A., et al. C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science 2013, 342:1508-1512.
8. Liu B., Wei L., Meyerle C., Tuo J., Sen H.N., Li Z., Chakrabarty S., Agron E., Chan C.C., Klein M.L., et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J.Transl. Med. 2011, 9:1-12.
9. Luhmann U.F., Carvalho L.S., Robbie S.J., Cowing J.A., Duran Y., Munro P.M., Bainbridge J.W., Ali R.R. Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degeneration. Exp. Eye Res. 2013, 107:80-87.
10. Luhmann U.F., Lange C.A., Robbie S., Munro P.M., Cowing J.A., Armer H.E., Luong V., Carvalho L.S., MacLaren R.E., Fitzke F.W., et al. Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling. PLoS One 2012, 7:e35551.
11. Lyzogubov V.V., Tytarenko R.G., Liu J., Bora N.S., Bora P.S. Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization. J.Biol. Chem. 2011, 286:16229-16237.
12. Mattapallil M.J., Wawrousek E.F., Chan C.C., Zhao H., Roychoudhury J., Ferguson T.A., Caspi R.R. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest. Ophthalmol. Vis. Sci. 2012, 53:2921-2927.
13. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
14. Mehalow A.K., Kameya S., Smith R.S., Hawes N.L., Denegre J.M., Young J.A., Bechtold L., Haider N.B., Tepass U., Heckenlively J.R., et al. CRB1 is essential for external limiting membrane integrity and photoreceptor morphogenesis in the mammalian retina. Hum. Mol. Genet. 2003, 12:2179-2189.
15. Mekada K., Abe K., Murakami A., Nakamura S., Nakata H., Moriwaki K., Obata Y., Yoshiki A. Genetic differences among C57BL/6 substrains. Exp. Anim. 2009, 58:141-149.
16. Nicholson A., Reifsnyder P.C., Malcolm R.D., Lucas C.A., MacGregor G.R., Zhang W., Leiter E.H. Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene. Obes. Silver Spring 2010, 18:1902-1905.
17. Pennesi M.E., Neuringer M., Courtney R.J. Animal models of age related macular degeneration. Mol. Asp. Med. 2012, 33:487-509.
18. Raoul W., Auvynet C., Camelo S., Guillonneau X., Feumi C., Combadiere C., Sennlaub F. CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J.Neuroinflammation 2010, 7:87.
19. Rohrer B., Long Q., Coughlin B., Wilson R.B., Huang Y., Qiao F., Tang P.H., Kunchithapautham K., Gilkeson G.S., Tomlinson S. Atargeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50:3056-3064.
20. Ronchi J.A., Figueira T.R., Ravagnani F.G., Oliveira H.C., Vercesi A.E., Castilho R.F. Aspontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities. Free Radic. Biol. Med. 2013, 63:446-456.
21. Schwartz S.G., Brantley M.A. Pharmacogenetics and age-related macular degeneration. J.Ophthalmol. 2011, 252549.
22. Simon M.M., Greenaway S., White J.K., Fuchs H., Gailus-Durner V., Wells S., Sorg T., Wong K., Bedu E., Cartwright E.J., et al. Acomparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol. 2013, 14:R82.
23. Tatar O., Adam A., Shinoda K., Stalmans P., Eckardt C., Luke M., Bartz-Schmidt K.U., Grisanti S. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am. J. Ophthalmol. 2006, 142:95-104.
24. Tuo J., Smith B.C., Bojanowski C.M., Meleth A.D., Gery I., Csaky K.G., Chew E.Y., Chan C.C. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J. 2004, 18:1297-1299.
25. Whitcup S.M., Sodhi A., Atkinson J.P., Holers V.M., Sinha D., Rohrer B., Dick A.D. The role of the immune response in age-related macular degeneration. Int. J. Inflam. 2013, 2013:348092.
26. Xu H., Chen M., Forrester J.V. Para-inflammation in the aging retina. Prog. Retin. Eye Res. 2009, 28:348-368.
27. Yalcin B., Adams D.J., Flint J., Keane T.M. Next-generation sequencing of experimental mouse strains. Mamm. Genome 2012, 23:490-498.
28. Yin F., Sancheti H., Cadenas E. Silencing of nicotinamide nucleotide transhydrogenase impairs cellular redox homeostasis and energy metabolism in PC12 cells. Biochim. Biophys. Acta 2012, 1817:401-409.
29. Zipfel P.F., Lauer N., Skerka C. The role of complement in AMD. Adv. Exp. Med. Biol. 2010, 703:9-24.